# A Window of Opportunity Study for Investigating Drug Tolerant Persister (DTP) to Neoadjuvant Osimertinib in Resectable Non-small Cell Lung Cancer (NSCLC) Harbouring EGFR Mutations

> **NCT04816838** · NA · UNKNOWN · sponsor: **Yonsei University** · enrollment: 25 (estimated)

## Conditions studied

- Non Small Cell Lung Cancer

## Interventions

- **DRUG:** Osimertinib

## Key facts

- **NCT ID:** NCT04816838
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-05-10
- **Primary completion:** 2025-07
- **Final completion:** 2025-10
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2021-08-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04816838

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04816838, "A Window of Opportunity Study for Investigating Drug Tolerant Persister (DTP) to Neoadjuvant Osimertinib in Resectable Non-small Cell Lung Cancer (NSCLC) Harbouring EGFR Mutations". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04816838. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*